Gain Therapeutics, Inc.GANXNASDAQ

Revenue (LTM)

-100.0% YoY

Net Income (LTM)

$-20M

+8.3% YoY

Free Cash Flow

$-19M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0↑363.7%	0↓1.0%	0↓58.4%	0
Gross Profit	0	-7↓24442.3%	-8↓15.4%	0↑100.7%	0
Operating Income	-3	-14↓297.4%	-18↓28.6%	-22↓25.2%	-20↑8.5%
Net Income	-4	-14↓288.3%	-18↓26.6%	-22↓26.6%	-20↑8.3%
EBITDA	-3	-14↓298.3%	-18↓28.5%	-22↓24.8%	-20↑8.6%
EPS Diluted	-0.30	-1.37↓356.7%	-1.48↓8.0%	-1.71↓15.5%	-0.89↑48.0%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	7	37↑392.2%	7↓80.2%	12↑61.3%	10↓11.9%
Total Current Assets	9	38↑319.7%	21↓44.1%	18↓15.7%	12↓34.7%
Total Assets	10	39↑305.9%	24↓38.2%	19↓22.8%	12↓34.9%
Total Current Liabilities	2	3↑20.7%	4↑61.6%	5↑20.0%	4↓21.0%
Total Liabilities	3	4↑22.5%	5↑25.3%	6↑15.5%	5↓20.7%
Total Equity	6	35↑461.4%	19↓45.8%	13↓33.4%	7↓41.6%
Total Debt	1	2↑27.5%	1↓20.8%	1↓19.4%	1↓36.4%
Net Debt	-6	-35↓466.0%	-6↑82.9%	-11↓78.3%	-10↑9.6%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-3	-12↓281.6%	-15↓18.8%	-19↓28.4%	-19↓0.0%
Capital Expenditure	-0	-0↓352.4%	-0↓26.3%	-0↑87.1%	-0↓46.5%
Free Cash Flow	-3	-12↓282.1%	-15↓18.9%	-19↓27.5%	-19↓0.1%
Stock-Based Comp	0	1↑928.1%	2↑81.9%	3↑113.5%	2↓26.7%
Net Change in Cash	7	29↑309.0%	-30↓200.6%	4↑115.2%	-1↓131.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance